Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 1Myeloid 1Classical hematology 1CNS 1

Conditions

Neuroblastoma 101Central Nervous System Neoplasms 37Medulloblastoma 35Brain Neoplasms 33Glioblastoma 20Sarcoma 16Rhabdoid Tumor 14Glioma 13Ependymoma 12Astrocytoma 11Osteosarcoma 10Neuroectodermal Tumors, Primitive 10Recurrence 9Neoplasms 9Lymphoma 9Breast Neoplasms 9Sarcoma, Ewing 8Oligodendroglioma 8Melanoma 8Ganglioneuroblastoma 8Choroid Plexus Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Ovarian Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Leukemia, Myeloid, Acute 7Gliosarcoma 7Rhabdomyosarcoma 6Multiple Myeloma 6Wilms Tumor 5

Interventions

Dexamethasone 2Zidovudine 1Vincristine 1Methotrexate 1Leucovorin 1Filgrastim 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Cyclophosphamide × CNS × Clear all
NCT00000801 2012-11-01

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
33 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡